Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Methylprednisolone Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Methylprednisolone Treatment Report

Brand Names: Solu-Medrol Infusion, Solu-Medrol, Methylprednisolone Infusion, Medrol DosePak, Methylprednisolone Dose Pack, Medrol
Generic Name: Methylprednisolone

What is Methylprednisolone? Methylprednisolone is a synthetic corticosteroid drug used primarily as an anti-inflammatory or immunosuppressant agent for diseases of hematologic, allergic, inflammatory, neoplastic, and autoimmune origin; also for graft-versus-host disease.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

808 patients in the community are taking or have taken Methylprednisolone.

Top 10 (Show all)

Reason # Patients Percentage of patients
Slow my MS progress 225 27%
Other 189 23%
Stiffness/Spasticity 43 5%
Pain 32 3%
relapse 31 3%
Vision 21 2%
Optic neuritis (inflammation, optic nerve) 21 2%
disease-related symptoms 20 2%
Sensation 18 2%
Fatigue 17 2%
General health 15 1%
Numbness, tingling, pins & needles (paresthesia) 12 1%
Mobility 11 1%
Support another treatment 9 1%
Exacerbation (relapse) MS 9 1%

Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a IM Injection, and Interferon beta-1a SubQ injection.

Dosages

Based on the patients currently taking Methylprednisolone.

Top 10 (Show all)

All (Show top 10)

  1000 as needed 1000 mg as needed 1000mg as needed 1 g as needed 1g as needed 1g monthly 1hours as needed 1mg as needed 1other as needed 20mg as needed 24mg as needed 250mg as needed 2g as needed 2 mg as needed 32mg as needed 3g as needed 40mg as needed 4 80mg/mL as needed 4 mg all the time (24/7) 4mg as needed 500mg as needed 50mg as needed 6 2mg as needed 80 mg as needed 8 500mg as needed as needed daily g as needed mg as needed monthly 3 g yearly 0.5 g monthly 1 g monthly 1 mEq/L monthly 1 monthly 1 other monthly 2 hr monthly 1 g every other week 1 mg every other week 3 g monthly 40 mg yearly 4 mg monthly 1 g weekly 64 mg yearly 1 daily 1 g daily 1 g one time 1 hr one time 40 mg monthly 60 mg monthly 2 hr daily 84 mg monthly 3 g daily 3 g one time 3 hr one time 100 mg monthly 4 g daily 4 mg daily 125 mg monthly 5 g one time 7.5 daily 8 mg daily 10 g daily 10 mg daily 12 mg daily 16 mg daily 500 mg monthly 20 mg daily 20 mg one time 1000 mg monthly 1024 mg monthly 40 mg daily 1500 mg monthly 50 intl units one time 50 mg daily 1000 mg every other week 500 mg weekly 80 mg daily 84 mg daily 96 mg daily 100 mg daily 1000 mg weekly 250 mg daily 250 mg one time 500 mg daily 1000 daily 1000 g daily 1000 mg daily 2000 mg daily
  3 Number of Patients: 3 1 Number of Patients: 1 12 Number of Patients: 12 2 Number of Patients: 2 18 Number of Patients: 18 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 11 Number of Patients: 11 18 Number of Patients: 18 1 Number of Patients: 1 3 Number of Patients: 3 7 Number of Patients: 7 1 Number of Patients: 1 1 Number of Patients: 1 25 Number of Patients: 25 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 24 Number of Patients: 24 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1 1 Number of Patients: 1 13 Number of Patients: 13 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 1 Number of Patients: 1 3 Number of Patients: 3 25 Number of Patients: 25 1 Number of Patients: 1  

Duration

How long current patients have been taking Methylprednisolone or how long patients were taking Methylprednisolone before stopping.

Currently Taking Methylprednisolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
6
11
15
30
30
45

Stopped Taking Methylprednisolone

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
333
30
23
33
33
77
Why Patients Stopped Taking Methylprednisolone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Course of treatment ended 438 84% Course of treatment ended: 84%
Doctor's advice 46 9% Doctor's advice: 9%
Did not seem to work 34 7% Did not seem to work: 7%
Side effects too severe 28 5% Side effects too severe: 5%
Other 26 5% Other: 5%
Not indicated 19 4% Not indicated: 4%
Personal research 3 1% Personal research: 1%

Patient Reported Evaluations

Results from 127 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 28% 10
Moderate 14% 5
Slight 31% 11
None 6% 2
Can't tell 22% 8

Slow my MS progress

Side-effects (as an overall problem)

Severe 19% 24
Moderate 39% 50
Mild 28% 35
None 14% 18

Top reported side-effects include: Taste changed, Weight gain, Sleeplessness

Summary results are based on 127 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 127)

  • Farmer in WI
    Sex: F
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
  • by Farmer in WI
    Aug 17, 2009
  • EfficacyCan't tell
  • Side-effectsSevere
  • help stop an exacerbation
Advice/Tips
Give it a chance. It affects each of us differently and helps each situation differently.

  • Flowers
    Sex: F
    Sensation: Severe
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
  • Flowers
  • by Flowers
    Aug 21, 2008
  • EfficacyMajor
  • Side-effectsSevere
  • Slow my MS progress
Advice/Tips
I know alot of people aren't into this treatment, but it's done wonders for me in the past and I will continue with it if I need to.

See all evaluation results for Methylprednisolone

Report created on November 08, 2009.